Pain Research Institute, Department of Translational Medicine, Liverpool University, Liverpool, UK.
Autoimmun Rev. 2013 Apr;12(6):682-6. doi: 10.1016/j.autrev.2012.10.015. Epub 2012 Dec 6.
Complex regional pain syndrome (CRPS) is a painful condition, which arises in a limb after trauma. CRPS can profoundly affect patients' quality of life, and there is no cure. CRPS is associated with limb-confined sensory, motor, skin, bone and autonomic abnormalities. Recent research has shown that some patients respond to treatment with immunoglobulins, and that a majority have IgG serum-autoantibodies directed against, and activating autonomic receptors. CRPS serum-IgG, when transferred to mice elicits abnormal behaviour. These results suggest that CRPS is associated with an autoantibody-mediated autoimmune process in some cases. CRPS has unusual features, including a non-destructive, and regionally-confined course. We propose that CRPS constitutes a prototype of a new kind of autoimmunity, which we term 'IRAM' (injury-triggered, regionally-restricted autoantibody-mediated autoimmune disorder with minimally-destructive course). Understanding autoimmune contribution to CRPS should allow the exploration of novel treatment modalities in the future. Additional 'functional' disorders, painful or painless may be autoimmune in nature.
复杂性区域疼痛综合征 (CRPS) 是一种在创伤后发生于肢体的疼痛性疾病。CRPS 会严重影响患者的生活质量,目前尚无治愈方法。CRPS 与肢体局限性感觉、运动、皮肤、骨骼和自主神经异常有关。最近的研究表明,一些患者对免疫球蛋白治疗有反应,且大多数患者的血清 IgG 针对并激活自主受体存在自身抗体。将 CRPS 血清 IgG 转移到小鼠中会引起异常行为。这些结果表明,在某些情况下,CRPS 与自身抗体介导的自身免疫过程有关。CRPS 具有异常特征,包括非破坏性和区域性受限的病程。我们提出 CRPS 构成了一种新型自身免疫的原型,我们称之为“IRAM”(损伤触发、区域性受限、自身抗体介导的自身免疫障碍,具有最小破坏性病程)。了解自身免疫对 CRPS 的贡献应该可以在未来探索新的治疗方法。其他可能具有疼痛或无痛的“功能性”障碍可能具有自身免疫性质。